Does Maternal Body Mass Index Affect the Quantity of Circulating Fetal Cells Available to Use for Cell-Based Noninvasive Prenatal Test in High-Risk Pregnancies?

類似資料

• Cell‐based noninvasive prenatal testing (cbNIPT) detects pathogenic copy number variations
  著者:: Hatt, Lotte, 等
  出版事項: (2020)
• The Number of Circulating Fetal Extravillous Trophoblasts Varies from Gestational Week 6 to 20
  著者:: Ravn, Katarina, 等
  出版事項: (2020)
• Hydatidiform mole diagnostics using circulating gestational trophoblasts isolated from maternal blood
  著者:: Sunde, Lone, 等
  出版事項: (2020)
• Do fetal extravillous trophoblasts circulate in maternal blood postpartum?
  著者:: van de Looij, Anne, 等
  出版事項: (2020)
• Danish Sonographers’ Experiences of the Introduction of “Moderate Risk” in Prenatal Screening for Down Syndrome
  著者:: Anne Møller, 等
  出版事項: (2018-01-01)